UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Transplant international, ISSN 0934-0874, 09/2014, Volume 27, Issue 9, pp. 956 - 965
graft survival | kidney transplant | calcineurin inhibitor | post‐transplant lymphoproliferative disorder | immunosuppression withdrawal | post-transplant lymphoproliferative disorder | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Postoperative Complications - etiology | Pancreas Transplantation | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Postoperative Complications - mortality | Creatine - blood | Renal Insufficiency - etiology | Lymphoproliferative Disorders - therapy | Young Adult | Graft Rejection - epidemiology | Epstein-Barr Virus Infections - etiology | Epstein-Barr Virus Infections - therapy | Adult | Female | Retrospective Studies | Radiotherapy, Adjuvant | Immunosuppressive Agents - administration & dosage | Kidney - physiopathology | Lymphoproliferative Disorders - etiology | Postoperative Complications - pathology | France - epidemiology | Glomerular Filtration Rate | Calcineurin Inhibitors - administration & dosage | Graft Rejection - prevention & control | Risk Factors | Proportional Hazards Models | Rituximab | Graft Rejection - etiology | Graft Survival | Postoperative Complications - therapy | Kidney Transplantation | Lymphoproliferative Disorders - pathology | Renal Insufficiency - mortality | Epstein-Barr Virus Infections - pathology | Calcineurin Inhibitors - adverse effects | Lymphoproliferative Disorders - mortality | Renal Insufficiency - therapy | Calcineurin Inhibitors - therapeutic use | Epstein-Barr Virus Infections - mortality | Immunosuppressive Agents - adverse effects | Aged | Immunocompromised Host | Drug Substitution | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Renal Dialysis | Index Medicus
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2016, Volume 139, Issue 2, pp. 597 - 606.e4
Allergy and Immunology | Recurrence | Humans | Middle Aged | Child, Preschool | Infant | Male | Antibiotic Prophylaxis | Class I Phosphatidylinositol 3-Kinases/antagonists & inhibitors | Young Adult | Immunoglobulins, Intravenous/therapeutic use | Enzyme Inhibitors/therapeutic use | Lymphoproliferative Disorders/genetics | Adult | Female | Surveys and Questionnaires | Child | Respiratory Tract Infections/genetics | Mutation/genetics | Hematopoietic Stem Cell Transplantation | International Cooperation | Herpesviridae Infections/genetics | Animals | Adolescent | Survival Analysis | Mice | Immunologic Deficiency Syndromes/genetics | Cohort Studies | Activated phosphoinositide 3-kinase δ syndrome | hematopoietic stem cell transplantation | phosphoinositide 3-kinase δ | immunodeficiency | phosphoinositide 3-kinase inhibitor | PIK3CD gene | bronchiectasis | p110δ-activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Class I Phosphatidylinositol 3-Kinases - genetics | Herpesviridae Infections - mortality | Respiratory Tract Infections - genetics | Lymphoproliferative Disorders - therapy | Respiratory Tract Infections - mortality | Respiratory Tract Infections - therapy | Immunologic Deficiency Syndromes - mortality | Herpesviridae Infections - genetics | Immunologic Deficiency Syndromes - therapy | Lymphoproliferative Disorders - genetics | Mutation - genetics | Class I Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Enzyme Inhibitors - therapeutic use | Lymphoproliferative Disorders - mortality | Herpesviridae Infections - therapy | Immunoglobulins, Intravenous - therapeutic use | Immunologic Deficiency Syndromes - genetics | Index Medicus | Abridged Index Medicus | Immune Deficiencies, Infection, and Systemic Immune Disorders | HSCT, Hematopoietic stem cell transplantation | BALF, Bronchoalveolar lavage fluid | CT, Computed tomography | APDS, Activated phosphoinositide-3 kinase δ syndrome | GOF, Gain of function | PI3K, Phosphoinositide 3-kinase | HSV, Herpes simplex virus | CMV, Cytomegalovirus | OR, Odds ratio | PPV, Pneumococcal polysaccharide vaccine | CNS, Central nervous system
Journal Article
Acta oncologica, ISSN 0284-186X, 06/2020, Volume 59, Issue 6, pp. 673 - 680
Life Sciences & Biomedicine | Oncology | Science & Technology | Hodgkin Disease - virology | T-Lymphocytes, Regulatory - metabolism | Hodgkin Disease - pathology | Humans | Middle Aged | Postoperative Complications - metabolism | Child, Preschool | Infant | Male | Lymphoma, Large B-Cell, Diffuse - metabolism | Postoperative Complications - mortality | Burkitt Lymphoma - mortality | Lymphoma, T-Cell - metabolism | Lymphoproliferative Disorders - metabolism | Burkitt Lymphoma - pathology | Young Adult | Herpesvirus 4, Human - isolation & purification | Postoperative Complications - virology | T-Lymphocytes, Regulatory - cytology | Hodgkin Disease - mortality | Lymphoma, T-Cell - virology | Adult | Female | Child | Postoperative Complications - pathology | Burkitt Lymphoma - virology | Hodgkin Disease - metabolism | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoproliferative Disorders - virology | Kaplan-Meier Estimate | Burkitt Lymphoma - metabolism | Ki-1 Antigen - metabolism | Lymphoproliferative Disorders - pathology | Lymphoma, Large B-Cell, Diffuse - virology | Lymphoma, Large B-Cell, Diffuse - mortality | Lymphoproliferative Disorders - mortality | Organ Transplantation - adverse effects | Adolescent | Forkhead Transcription Factors - analysis | Lymphoma, T-Cell - pathology | Aged | Lymphoma, T-Cell - mortality | Index Medicus
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2014, Volume 134, Issue 1, pp. 116 - 126.e11
Allergy and Immunology | patient self-reported outcomes | treatment | Common variable immunodeficiency | primary antibody deficiency | autoimmunity | enteropathy | immunoglobulin replacement | quality of life | lymphadenopathy | granulomas | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Fundamental and applied biological sciences. Psychology | Fundamental immunology | Immunopathology | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Biological and medical sciences | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Autoimmunity | Common Variable Immunodeficiency - immunology | Common Variable Immunodeficiency - drug therapy | Humans | Child, Preschool | Lymphoproliferative Disorders - complications | Male | Lymphoproliferative Disorders - immunology | Splenomegaly - pathology | Bronchiectasis - pathology | Common Variable Immunodeficiency - mortality | Pneumonia - mortality | Pneumonia - immunology | Adult | Female | Retrospective Studies | Child | Europe | Delayed Diagnosis | Common Variable Immunodeficiency - complications | Lymphoproliferative Disorders - mortality | Pneumonia - drug therapy | Immunoglobulins, Intravenous - therapeutic use | Adolescent | Age of Onset | Survival Analysis | Pneumonia - complications | Lymphoproliferative Disorders - drug therapy | Immunological deficiency syndromes | Care and treatment | Health aspects | Respiratory tract diseases | Studies | Pneumonia | Databases | Meningitis | Multivariate analysis | Patients | Lymphoma | Age | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
British journal of haematology, ISSN 0007-1048, 06/2018, Volume 181, Issue 6, pp. 752 - 759
socioeconomic factors | primary cutaneous CD30+ T‐cell lymphoproliferative disorders | ethnicity | prognosis | NCDB | primary cutaneous CD30 | T-cell lymphoproliferative disorders | Life Sciences & Biomedicine | Hematology | Science & Technology | United States - epidemiology | Age Factors | Follow-Up Studies | Humans | Middle Aged | Male | Lymphoproliferative Disorders - therapy | Socioeconomic Factors | Lymphoproliferative Disorders - ethnology | Skin Neoplasms - mortality | Neoplasm Proteins | Head and Neck Neoplasms - ethnology | Adult | Female | Retrospective Studies | Databases, Factual | Skin Neoplasms - therapy | T-Lymphocytes | United States - ethnology | Head and Neck Neoplasms - therapy | Skin Neoplasms - ethnology | Survival Rate | Ki-1 Antigen | Disease-Free Survival | Lymphoproliferative Disorders - mortality | Sex Factors | Aged | Head and Neck Neoplasms - mortality | Chemotherapy | Databases | Analysis | African Americans | Rankings | Non-Hodgkin's lymphomas | T cells | Cancer | Disorders | Economic factors | Lymphocytes T | Social factors | Multivariate analysis | Socioeconomics | Data bases | Rank tests | Matching | Demographics | CD30 antigen | Lymphocytes | Head and neck | Medical treatment | Immunoproliferative diseases | Socio-economic aspects | Regression analysis | Cultural differences | Minority & ethnic groups | Patients | Survival | Lymphoma | Ethnicity | Socioeconomic factors | Medical prognosis | Index Medicus
Journal Article
Transplantation, ISSN 0041-1337, 10/2009, Volume 88, Issue 7, pp. 926 - 934
De novo malignancy | Intestinal transplantation | Posttransplant lymphoproliferative disorders | Recipient pretreatment with ratg and alemtuzumab | Transplantation | Immunology | Life Sciences & Biomedicine | Surgery | Science & Technology | Fundamental and applied biological sciences. Psychology | Hematologic and hematopoietic diseases | Fundamental immunology | Tissue, organ and graft immunology | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases | Age Factors | Lymphocyte Depletion - mortality | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Child, Preschool | Postoperative Complications - mortality | Antilymphocyte Serum - therapeutic use | Adult | Retrospective Studies | Drug Therapy, Combination | Child | Organ Transplantation - mortality | Viscera - transplantation | Rabbits | Antiviral Agents - therapeutic use | Risk Factors | Neoplasms - mortality | Survival Rate | Postoperative Complications - epidemiology | Organ Transplantation - statistics & numerical data | Lymphoproliferative Disorders - epidemiology | Lymphoproliferative Disorders - mortality | Animals | Adolescent | Aged | Intestines - transplantation | Neoplasms - epidemiology | Graft-versus-host reaction | posttransplant lymphoproliferative disorders | Malignancy | Multivariate analysis | Immunosuppressive agents | Risk factors | Splenectomy | Early experience | Intestine | Children | Antilymphocyte serum | Adoption | Age | Antiviral agents | Mortality | Immunoproliferative diseases | Survival | Morbidity | Graft rejection | Cyclophosphamide | Immunosuppression | Donors | Tacrolimus | Monoclonal antibodies | Cancer | Index Medicus
Journal Article
American journal of transplantation, ISSN 1600-6135, 11/2006, Volume 6, Issue 11, pp. 2735 - 2742
EBV | HCV | post-transplant lymphoproliferative disorders | French Registry | kidney transplantation | post‐transplant lymphoproliferative disorders | Post-transplant lymphoproliferative disorders | Kidney transplantation | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases | Surgery of the urinary system | Prognosis | Follow-Up Studies | Humans | Risk Factors | Male | Postoperative Complications - epidemiology | Incidence | Lymphoproliferative Disorders - epidemiology | Lymphoproliferative Disorders - mortality | Time Factors | Survival Analysis | Aging | Adult | Female | Kidney Transplantation - mortality | Registries | France | Kidney Transplantation - immunology | Kidney Transplantation - adverse effects | Kidneys | Index Medicus
Journal Article
American journal of transplantation, ISSN 1600-6135, 08/2013, Volume 13, Issue 8, pp. 2146 - 2153
CD30 positive lymphoma | B cell | skin cancer | posttransplant lymphoproliferative disorder | organ transplantation | T cell | posttransplant lymphoma | immunosuppressant therapy | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Hematologic and hematopoietic diseases | Public health. Hygiene-occupational medicine | Public health. Hygiene | Miscellaneous | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases | Prognosis | Follow-Up Studies | Lymphoma, T-Cell, Cutaneous - mortality | Lymphoma, T-Cell, Cutaneous - diagnosis | Humans | Middle Aged | Risk Factors | Male | Mycosis Fungoides - etiology | Survival Rate | Lymphoma, T-Cell, Cutaneous - etiology | Lymphoproliferative Disorders - mortality | Lymphoproliferative Disorders - diagnosis | International Agencies | Skin Neoplasms - mortality | Organ Transplantation - adverse effects | Skin Neoplasms - diagnosis | Female | Mycosis Fungoides - mortality | Retrospective Studies | Skin Neoplasms - etiology | Postoperative Complications | Lymphoproliferative Disorders - etiology | Mycosis Fungoides - diagnosis | Mycoses | Transplantation of organs, tissues, etc | Organ transplant recipients | Skin | Non-Hodgkin's lymphomas | T cells | Immunosuppressive agents | Skin cancer | Population | Transplants & implants | Lymphocytes | Lymphoma | Index Medicus | B-cell lymphoma
Journal Article
Cancer, ISSN 0008-543X, 02/2010, Volume 116, Issue 4, pp. 863 - 870
Rituximab | Transplantation | Post-transplantation lymphoproliferative disorder | Lymphoma | Central nervous system | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Central Nervous System Diseases - pathology | Age Factors | Central Nervous System Diseases - epidemiology | Humans | Middle Aged | Child, Preschool | Male | Combined Modality Therapy | Lymphoproliferative Disorders - pathology | Lymphoproliferative Disorders - epidemiology | Lymphoproliferative Disorders - mortality | Lymphoproliferative Disorders - diagnosis | Time Factors | Organ Transplantation - adverse effects | Adolescent | Adult | Female | Immunosuppressive Agents - adverse effects | Central Nervous System Diseases - diagnosis | Central Nervous System Diseases - mortality | Child | Postoperative Complications | Transplantation of organs, tissues, etc | Complications and side effects | Lymphoproliferative disorders | Research | Patient outcomes | Epstein-Barr virus diseases | Index Medicus | Abridged Index Medicus | post-transplantation lymphoproliferative disorder | rituximab | lymphoma | transplantation | central nervous system
Journal Article